These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 906465)

  • 1. [Combined treatment with furosemide, aldactone and hygroton in chronic right-ventricular circulatory failure].
    Florkiewicz H; Rymar B; Rumiński W; Staśkiewicz J
    Wiad Lek; 1977 Aug; 30(15):1171-5. PubMed ID: 906465
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone in patients with heart failure.
    Fernandez HM; Leipzig RM
    N Engl J Med; 2000 Jan; 342(2):132; author reply 133-4. PubMed ID: 10636750
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple therapy can achieve striking reductions in frusemide dosage.
    Jolobe OM
    Cardiology; 2009; 114(4):271; author reply 272. PubMed ID: 19684397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute tubular necrosis caused by combination of diuretics in the treatment of several heart failure. A call to attention].
    de Luis DA; Liaño F; Pascual J; Ortuño J
    Rev Clin Esp; 1997 Aug; 197(8):592-3. PubMed ID: 9312802
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C; Donker AJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of calcium antagonists combined with digoxin and furosemide in hypertension complicated by circulatory insufficiency in elderly patients].
    Orynchak MA
    Klin Med (Mosk); 1990 Jul; 68(7):56-60. PubMed ID: 2232650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spironolactone, potassium chloride and hyperkalemia in patients with kidney failure].
    Elo H
    Duodecim; 1992; 108(19):1708-10. PubMed ID: 1366200
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
    Bachour G
    Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone.
    Khan MI
    Can Med Assoc J; 1980 Nov; 123(9):883-7. PubMed ID: 7437992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of using nifedipine by patients with chronic congestive heart failure treated with digoxin and furosemide].
    Markiewicz K; Górski L; Cholewa M; Gawor Z; Dryjański T
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):461-5. PubMed ID: 2277789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone use in patients with heart failure.
    Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldactone in the complex treatment of circulatory insufficiency in elderly patients].
    Morozov KA; Goriainova AN
    Kardiologiia; 1976 Nov; 16(11):150-1. PubMed ID: 1011458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.